183 related articles for article (PubMed ID: 17138824)
21. Inhibition of adenosine monophosphate-activated protein kinase suppresses bone morphogenetic protein-2-induced mineralization of osteoblasts via Smad-independent mechanisms.
Takeno A; Kanazawa I; Notsu M; Tanaka KI; Sugimoto T
Endocr J; 2018 Mar; 65(3):291-298. PubMed ID: 29249772
[TBL] [Abstract][Full Text] [Related]
22. Elevated hepatocyte growth factor levels in osteoarthritis osteoblasts contribute to their altered response to bone morphogenetic protein-2 and reduced mineralization capacity.
Abed E; Bouvard B; Martineau X; Jouzeau JY; Reboul P; Lajeunesse D
Bone; 2015 Jun; 75():111-9. PubMed ID: 25667190
[TBL] [Abstract][Full Text] [Related]
23. 3,5-dicaffeoyl‑epi-quinic acid from Atriplex gmelinii enhances the osteoblast differentiation of bone marrow-derived human mesenchymal stromal cells via WnT/BMP signaling and suppresses adipocyte differentiation via AMPK activation.
Karadeniz F; Oh JH; Lee JI; Seo Y; Kong CS
Phytomedicine; 2020 Jun; 71():153225. PubMed ID: 32464299
[TBL] [Abstract][Full Text] [Related]
24. Tridax procumbens flavonoids promote osteoblast differentiation and bone formation.
Al Mamun MA; Hosen MJ; Islam K; Khatun A; Alam MM; Al-Bari MA
Biol Res; 2015 Nov; 48():65. PubMed ID: 26581452
[TBL] [Abstract][Full Text] [Related]
25. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
26. Dimethyloxalylglycine Promotes Bone Marrow Mesenchymal Stem Cell Osteogenesis via Rho/ROCK Signaling.
Zhang L; Jiang G; Zhao X; Gong Y
Cell Physiol Biochem; 2016; 39(4):1391-403. PubMed ID: 27606625
[TBL] [Abstract][Full Text] [Related]
27. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
[TBL] [Abstract][Full Text] [Related]
28. Phlorofucofuroeckol A from Edible Brown Alga
Oh JH; Ahn BN; Karadeniz F; Kim JA; Lee JI; Seo Y; Kong CS
Mar Drugs; 2019 Sep; 17(10):. PubMed ID: 31546680
[TBL] [Abstract][Full Text] [Related]
29. deltaEF1 represses BMP-2-induced differentiation of C2C12 myoblasts into the osteoblast lineage.
Yang S; Zhao L; Yang J; Chai D; Zhang M; Zhang J; Ji X; Zhu T
J Biomed Sci; 2007 Sep; 14(5):663-79. PubMed ID: 17479358
[TBL] [Abstract][Full Text] [Related]
30. CCN3 Facilitates Runx2 and Osterix Expression by Inhibiting miR-608 through PI3K/Akt Signaling in Osteoblasts.
Chen PC; Liu JF; Fong YC; Huang YL; Chao CC; Tang CH
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284378
[TBL] [Abstract][Full Text] [Related]
31. Ethanol extract of Lithospermum erythrorhizon Sieb. et Zucc. promotes osteoblastogenesis through the regulation of Runx2 and Osterix.
Choi YH; Kim GS; Choi JH; Jin SW; Kim HG; Han Y; Lee DY; Choi SI; Kim SY; Ahn YS; Lee KY; Jeong HG
Int J Mol Med; 2016 Aug; 38(2):610-8. PubMed ID: 27353217
[TBL] [Abstract][Full Text] [Related]
32. Decrease of MiR-31 induced by TNF-α inhibitor activates SATB2/RUNX2 pathway and promotes osteogenic differentiation in ethanol-induced osteonecrosis.
Yu L; Xu Y; Qu H; Yu Y; Li W; Zhao Y; Qiu G
J Cell Physiol; 2019 Apr; 234(4):4314-4326. PubMed ID: 30132874
[TBL] [Abstract][Full Text] [Related]
33. Sprouty2 is involved in the control of osteoblast proliferation and differentiation through the FGF and BMP signaling pathways.
Taketomi T; Onimura T; Yoshiga D; Muratsu D; Sanui T; Fukuda T; Kusukawa J; Nakamura S
Cell Biol Int; 2018 Sep; 42(9):1106-1114. PubMed ID: 28921936
[TBL] [Abstract][Full Text] [Related]
34. BMP responsiveness in human mesenchymal stem cells.
Diefenderfer DL; Osyczka AM; Reilly GC; Leboy PS
Connect Tissue Res; 2003; 44 Suppl 1():305-11. PubMed ID: 12952214
[TBL] [Abstract][Full Text] [Related]
35. The proteasome inhibitor bortezomib inhibits FGF-2-induced reduction of TAZ levels in osteoblast-like cells.
Eda H; Aoki K; Kato S; Okawa Y; Takada K; Tanaka T; Marumo K; Ohkawa K
Eur J Haematol; 2010 Jul; 85(1):68-75. PubMed ID: 20192985
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow stromal cells from low-turnover osteoporotic mouse model are less sensitive to the osteogenic effects of fluvastatin.
Oda Y; Sasaki H; Miura T; Takanashi T; Furuya Y; Yoshinari M; Yajima Y
PLoS One; 2018; 13(8):e0202857. PubMed ID: 30142209
[TBL] [Abstract][Full Text] [Related]
37. Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation.
Giuliani N; Colla S; Morandi F; Lazzaretti M; Sala R; Bonomini S; Grano M; Colucci S; Svaldi M; Rizzoli V
Blood; 2005 Oct; 106(7):2472-83. PubMed ID: 15933061
[TBL] [Abstract][Full Text] [Related]
38. Trapidil induces osteogenesis by upregulating the signaling of bone morphogenetic proteins.
Kim B; Lee JH; Jin WJ; Kim HH; Ha H; Lee ZH
Cell Signal; 2018 Sep; 49():68-78. PubMed ID: 29879471
[TBL] [Abstract][Full Text] [Related]
39. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
40. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation.
van Dinther M; Visser N; de Gorter DJ; Doorn J; Goumans MJ; de Boer J; ten Dijke P
J Bone Miner Res; 2010 Jun; 25(6):1208-15. PubMed ID: 19929436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
